Iterum Therapeutics PLC (ITRM) — Financial Flexibility Index
Iterum Therapeutics PLC (ITRM) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-7.84 Million (operating CF $-7.85 Million minus capex $12.57K) represents 0% of total liabilities ($39.88 Million). Also explore Iterum Therapeutics PLC (ITRM) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iterum Therapeutics PLC Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Iterum Therapeutics PLC across 9 annual periods. Check ITRM PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Iterum Therapeutics PLC (2016–2024)
Year-by-year free cash flow to debt coverage for Iterum Therapeutics PLC. For the full company profile including market capitalisation, see Iterum Therapeutics PLC stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | $-26.77 Million | $-26.77 Million | $48.68 Million | ▲ +54.3% |
| 2023 | -1.20x | $-39.32 Million | $-39.33 Million | $32.66 Million | ▼ -153.9% |
| 2022 | -0.47x | $-18.41 Million | $-18.47 Million | $38.83 Million | ▼ -24.0% |
| 2021 | -0.38x | $-15.78 Million | $-15.84 Million | $41.27 Million | ▲ +41.5% |
| 2020 | -0.65x | $-54.52 Million | $-54.53 Million | $83.35 Million | ▲ +58.5% |
| 2019 | -1.58x | $-81.90 Million | $-81.92 Million | $51.99 Million | ▲ +45.4% |
| 2018 | -2.89x | $-75.80 Million | $-75.89 Million | $26.25 Million | ▲ +29.6% |
| 2017 | -4.10x | $-29.79 Million | $-30.60 Million | $7.26 Million | ▼ -66.2% |
| 2016 | -2.47x | $-10.49 Million | $-11.30 Million | $4.25 Million | — |